CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

The scarce resource in the SDLC is no longer engineering hours developing features, but rather the trust that a particular ...

Grifols (GRFS) is a strong buy for investors—robust Q2 results, reduced leverage, and 100%+ upside potential. Read more ...

AlignBase recently closed an angel funding round, raising more than RMB 100 million (USD 14 million) from a slate of ...

Artificial intelligence has taken many forms over the years and is still evolving. Will machines soon surpass human knowledge and understanding?

Aging of the brain is characterized by deleterious processes at various levels including cellular/molecular and ...

Learn how the Economic Value of Equity (EVE) helps banks manage assets, understand interest rate risks, and its limitations ...